Vascular-targeting agent
Appearance
A vascular-targeting agent (VTA) or vascular disrupting agent (VDA) is a drug designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis.[1]
VTAs can be small-molecule or ligand-based.
Small-molecule VTAs include :
- microtubulin destabilizing drugs such as combretastatin A-4 disodium
phosphate, ZD6126, AVE8062, Oxi 4503,
- the flavonoid, DMXAA
References
- ^ http://clincancerres.aacrjournals.org/cgi/reprint/10/2/415.pdf "Vascular Targeting Agents as Cancer Therapeutics" 2004